Written by Meghna Nandi, MD Depot Medroxyprogesterone Acetate (DMPA) is a commonly used, highly efficacious, progestin-only injectable contraceptive method. Many contraceptive users are drawn to DMPA for the privacy it affords and the convenience of its three-month (11-15 week) dosing schedule.1 Although DMPA has many advantages, there are concerns over the method’s impact on bone…
This Insight is an update to a previous Contraceptive Pearl article published in May 2021. After an abortion, patients may want to start or change contraception. Depending on a patient’s medical eligibility, the following contraceptive methods are safe and effective post-abortion: Estrogen/progestin pill, patch, ring Progestin-only pill, injection, implant, IUD Copper IUD Barrier methods Sterilization…
This workshop was developed for clinicians who would like to learn more about medication abortion and incorporate medication abortion into their practice. The workshop includes both a didactic presentation and participatory case study exploration. If you are interested in CME or CNE credit, you can request a workshop. Participation in a live workshop is required for…
Written by Eleanor Bimla Schwarz, MD, MS and Kelly M. Treder, MD, MPH Since the Dobbs decision, as access to abortion services has become more challenging in many parts of the country, the possibility of contraceptive failure has become more distressing. Unintended pregnancy is relatively common, even among patients who use contraception.1 Because many patients…
Written by Rory Tito, MPH Early pregnancy loss (EPL), also known as miscarriage or spontaneous abortion, is the loss of a pregnancy in the first trimester (12 6/7 weeks) of pregnancy. EPL happens in 10% of clinically recognized pregnancies, and 1 in 4 people with the ability to get pregnant will experience EPL in their…